Cidara Thera
(CDTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 7,225 | 7,076 | 32,863 | 2,408 | 3,729 |
| Gross Profit | 7,225 | 7,076 | 32,863 | 2,408 | 3,729 |
| Operating Expenses | 23,995 | 25,112 | 22,090 | 20,630 | 25,277 |
| Operating Income | -16,770 | -18,036 | 10,773 | -18,222 | -21,548 |
| Interest Expense | 0 | 0 | 62 | 70 | 0 |
| Other Income | -33 | -47 | 0 | 0 | -86 |
| Pre-tax Income | -16,803 | -18,083 | 10,711 | -18,292 | -21,634 |
| Net Income Continuous | -16,803 | -18,083 | 10,711 | -18,292 | -21,634 |
| Net Income | $-16,803 | $-18,083 | $10,711 | $-18,292 | $-21,634 |
| EPS Basic Total Ops | -4.60 | -7.40 | 3.60 | -7.80 | -9.60 |
| EPS Basic Continuous Ops | -5.50 | -7.30 | 4.40 | -7.79 | -9.92 |
| EPS Diluted Total Ops | -4.60 | -7.40 | 3.60 | -7.80 | -9.60 |
| EPS Diluted Continuous Ops | -4.71 | -7.30 | 3.61 | -7.79 | -9.92 |
| EBITDA(a) | $-18,820 | $-17,744 | $11,040 | $-17,958 | $-20,716 |